Chiron Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FT Vest SMID Rising Dividend Achievers Target Income ETF
SDVD
|
+$1.37M |
| 2 |
Albemarle
ALB
|
+$1.02M |
| 3 |
ExxonMobil
XOM
|
+$897K |
| 4 |
Nike
NKE
|
+$793K |
| 5 |
Kimberly-Clark
KMB
|
+$783K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$4.5M |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$1.77M |
| 3 |
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
|
+$1.21M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$974K |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$621K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.42% |
| 2 | Consumer Staples | 9.15% |
| 3 | Financials | 8.74% |
| 4 | Communication Services | 7.45% |
| 5 | Energy | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
| – | – |
-6,642
| Closed | -$594K |
|
Similar funds
Chiron Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Chiron Capital Management held 126 positions worth $110M, down 4.2% from $115M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Chiron Capital Management withdrew a net $9.99M in Q1 2024, closing 18 positions and reducing 53 holdings. Its most notable exit was State Street Technology Select Sector SPDR ETF, an estimated $1.77M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 27% a quarter earlier, followed by Consumer Staples and Financials.
Against the trend, Chiron Capital Management opened a new position in FT Vest SMID Rising Dividend Achievers Target Income ETF worth $1.45M.
- Chiron Capital Management's largest Q1 2024 buy was FT Vest SMID Rising Dividend Achievers Target Income ETF: 65,968 shares worth $1.45M.
- Chiron Capital Management added most to Albemarle in Q1 2024, an estimated $1.02M increase.
- Chiron Capital Management's biggest Q1 2024 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $4.5M.
- Chiron Capital Management fully exited State Street Technology Select Sector SPDR ETF in Q1 2024, selling an estimated $1.77M.
- Chiron Capital Management's ten largest holdings make up 44% of its $110M portfolio in Q1 2024.
- Chiron Capital Management opened 9 new positions and closed 18 in Q1 2024.
- Chiron Capital Management's portfolio value fell 4.2% quarter-over-quarter to $110M.
Based on Chiron Capital Management's 13F filing for Q1 2024, filed 10 May 2024.